The 1 January 1980 cut-off and why it was chosen

The 1 January 1980 date marks the beginning of the period during which the UK cattle herd was exposed to BSE (bovine spongiform encephalopathy) at scale, and during which humans began consuming affected beef products. The theoretical link between BSE exposure and variant CJD in humans was established in the mid-1990s when the first cases of vCJD were identified.

Because blood transfusions received during this period could in theory have transmitted vCJD from an infected donor to a recipient, NHS Blood and Transplant took the precautionary decision to permanently exclude anyone who received a UK blood transfusion after this date from donating. The risk is theoretical, not established, but given that vCJD is fatal and incurable and that no reliable pre-symptomatic test exists, a precautionary permanent exclusion was judged to be the appropriate response.

What variant CJD is and why it matters

Variant Creutzfeldt-Jakob disease is caused by an abnormal form of a protein called a prion. Unlike bacteria and viruses, prions cannot be destroyed by standard sterilisation or blood screening processes. The disease destroys brain tissue progressively and is invariably fatal. It has a very long and variable incubation period, potentially measured in decades, during which an infected person shows no symptoms but may theoretically be capable of transmitting the prion through blood.

The impossibility of screening donated blood for vCJD prions, combined with the severity of the disease and the length of its incubation period, means that the only safe approach is to exclude from donation anyone in the at-risk group entirely. This is a population-level precaution, not a judgement about any individual's health or the likelihood that any specific person is infected.

Transfusions received outside the UK

If you received a blood transfusion outside the UK, the position is different. The vCJD deferral is specifically linked to the UK BSE epidemic and the UK blood supply during the affected period. Transfusions received in other countries do not carry the same vCJD-related concern.

However, transfusions received abroad are still assessed individually, because blood transfusion anywhere involves a significant medical event and the underlying cause of the transfusion will be considered as part of your overall health history. You should declare any transfusion received outside the UK at your appointment and staff will advise you on your specific situation.

Transfusions received before 1 January 1980

A transfusion received in the UK before 1 January 1980 does not trigger the vCJD-related deferral. The BSE epidemic is dated from approximately 1980 onwards and the precautionary exclusion applies only from that point.

If you received a UK transfusion before this date, you may still be eligible to donate. Your overall health history, including the medical reason for the transfusion, will still be assessed as part of the standard eligibility process. Declare the transfusion at your appointment and staff will confirm whether you are eligible to proceed.

Other blood products and the scope of the deferral

The UK post-1980 transfusion deferral applies to whole blood, packed red blood cells, platelets and fresh frozen plasma. If you received any of these from the UK blood supply after 1 January 1980, you are permanently excluded from donating whole blood, platelets or plasma in the UK.

Albumin, immunoglobulins and clotting factors manufactured from pooled plasma are treated differently as they undergo processes that inactivate prions. Receipt of these products does not automatically trigger the same deferral. If you are uncertain about the category of blood product you received, declare this at your appointment or contact the helpline for clarification before attending.